Arutiunov G P, Tarlovskaia E I, Koziolova N A, Boldina M V, Batiushin M M, Ametov A S, Arutiunov A G, Belevskii A S, Galstian G R, Grigor'eva N I, Dzhunusbekova G A, Esaian A M, Mal'chikova S V, Mit'kovskaia N P, Mkrtumian A M, Orlova I A, Petrova M M, Rebrov A P, Ruzanov D I, Salukhov V V, Sisakian A S, Skibitskii V V, Sugraliev A B, Fomin I V, Khalimov I S, Chesnikova A I, Shaposhnik I I, Shestakova M V
Pirogov Russian National Research Medical University.
Volga Research Medical University.
Ter Arkh. 2020 Oct 14;92(9):108-124. doi: 10.26442/00403660.2020.09.000703.
The agreement of experts of the Eurasian Association of Therapists (EAT) discusses pathogenesis and treatment of COVID-19. Modern data on the characteristics of cardiovascular, kidney, respiratory damage in SARS-infected CoV-2 are presented. The tactics of managing patients initially having cardiovascular diseases, diabetes mellitus, chronic obstructive pulmonary disease, bronchial asthma, chronic kidney disease are discussed in detail. The article presents data on drug interaction of drugs.
欧亚治疗师协会（EAT）专家的协议讨论了新冠病毒病（COVID-19）的发病机制和治疗方法。文中介绍了关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染所致心血管、肾脏、呼吸损害特征的最新数据。详细讨论了对最初患有心血管疾病、糖尿病、慢性阻塞性肺疾病、支气管哮喘、慢性肾脏病患者的管理策略。本文还展示了药物相互作用的数据。
